Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$203K Buy
1,778
+12
+0.7% +$1.41K 0.01% 1307
2026
Q2
$188K Sell
1,766
-48
-3% -$5.81K 0.01% 1311
2026
Q1
$297K Buy
1,814
+141
+8% +$21.7K 0.01% 852
2025
Q4
$291K Buy
1,673
+506
+43% +$92.3K 0.01% 783
2025
Q3
$168K Buy
1,167
+367
+46% +$45K 0.01% 1101
2025
Q2
$80.5K Sell
800
-209
-21% -$16K 0.01% 1602
2025
Q1
$77K Buy
1,009
+386
+62% +$29.5K 0.01% 1465
2024
Q4
$43K Buy
623
+85
+16% +$6.12K ﹤0.01% 1779
2024
Q3
$39.3K Buy
538
+224
+71% +$16.5K ﹤0.01% 1670
2024
Q2
$21K Buy
314
+101
+47% +$3.92K ﹤0.01% 1822
2024
Q1
$5.78K Buy
213
+18
+9% +$504 ﹤0.01% 2347
2023
Q4
$5.42K Buy
+195
New +$5.06K ﹤0.01% 2202

Other funds holding INSM

GAMMA Investing's INSM Position: Q3 2026 in Review

GAMMA Investing increased its Insmed (INSM) stake by 0.68% in Q3 2026, buying an estimated $1.41K and bringing the position to 1,778 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #1307.

GAMMA Investing first reported a position in INSM in Q4 2023 and has held it in 12 quarters since. The position peaked at $297K in Q1 2026. 16 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • GAMMA Investing held 1,778 shares of Insmed worth $203K as of Q3 2026.
  • GAMMA Investing bought 12 Insmed shares in Q3 2026, an estimated $1.41K.
  • Insmed made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #1307 holding.
  • GAMMA Investing first reported a position in Insmed in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Insmed position peaked at $297K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.